• About Holy Cross Hospital
• Our services
• Health information
• Classes and events
• Find a physician
• For patients & visitors
• Online bill payment
• Online nursery
• Career opportunities
• For physicians
• For our staff
• Ways to give
• Media
• e-Newsletter
• Virtual tour

Cancer Research Studies
Prevention & Early Detection: Lung Cancer

Study Title:
International Early Lung Cancer Action Project

Study Title:
I-ELCAP-Legacy Lung Screening and Smoking Cessation Project

What is the purpose of this study?
The purpose of this study is to determine whether a CT scan can detect lung cancer or other diseases in the early stages. A CT scan can detect tiny spots on your lungs many years before the spots can be seen on a chest x-ray. Early detection is our best hope for effective treatment and possible cure for lung cancer.

The Legacy Study also examines the impact of providing smoking cessation advice and counseling practices on smoking behavior and smoking related health beliefs in smokers seeking lung cancer screening

Am I a candidate for this study?
To be a candidate for this study:

• You must be at least 50 years old.
• You must have you smoked the equivalent of one pack per day for 10 years.
• If you are a current smoker, would you consider quitting?
• You must be physically fit enough to have lung surgery if necessary.
• You must have a primary care physician.

What do I need to do?
To participate in this lung cancer research study:

• You will need to complete a detailed questionnaire.
• You will undergo a free low-dose CT (CAT, Computed tomography) scan of the chest to see if you have any abnormalities in your chest.
• If no abnormalities exist, you will be scheduled for another free CT scan one year after your first scan.
• If you have abnormalities, other tests or procedures might be recommended to you and your physician as follow-up.
• If you are a current smoker, you may be randomized to receive brief smoking cessation counseling session prior to your first CT Scan.
• You will participate in the study for 12 months, but you can stop participating at any time.

If you are interested in participating in this lung cancer research study, please contact:
Yonas Assefa, research assistant
Holy Cross Hospital, Clinical Research Department
301.754.7695
Assefy@holycrosshealth.org
lungcarecenter@holycrosshealth.org

Ana Fighetti, bilingual research assistant (Spanish)
301.754.7998

Principle Investigator for I-ELCAP:
Cheryl Aylesworth, MD, medical oncologist

Principle Investigator for Legacy:
Kashif Firozvi, MD, medical oncologist

Return to top.